INTRODUCTION
Autism spectrum disorder (ASD) is neurodevelopmental disorder characterized by deficits in communication, social interaction and increased repetitive behavior. ASD has a complex genetic contribution interacting betweeen multiple genes and environmental factors (1) . However, there has not yet been made an exclusive explanation of etiopathogenesis of autism.
The ubiquitin-proteasome system (UPS) is a major non-lysosomal proteolytic process that regulates the levels of cellular proteins including those involved in neuronal growth and function. Findings suggest that ubiquitination and related proteins play major roles in synaptic plasticity (2, 3) . Furthermore, UPS system is involved in neurodegenerative disorders such as Alzheimer' s and Huntington' s disease (3) . In addition to these, deficit or excess UBE3A leads to autistic symptoms in Angelman syndrome. UBE3A is regulated by phosphorylation and that an autism-linked mutation causes impairing regulation of phosphorylation and synapse formation (4, 5) . It is thought that abnormal UBE3A activity contributes to neuropathological features in autism (5) . As phosphorylation of UBE3A enables synapse development (6, 7) , it was reported that there was close relationship between phosphorylation of ubiquination and dendritic spine density (5, 8, 9, 10) . Moreover, in UBA6 brain-specific knock-out Mouse, it was revealed that autistic symptoms were observed in absence of UBA6 (1) . Therefore, abnormalities in ubiqunation system might be related with autistic pathology.
There are some molecules in UPS, brain and blood levels or pathophysiological role have not been investigated in autism. Ubiquitin C-terminal hydrolase-L1 (UCH-L1), 223 amino acid proteins (25 kDa) (11, 12) are highly and specifically expressed in neurons, and have been useful as a histological marker. It is involved in the process of ubiquitination of proteins destined for degradation via the proteosomal pathway to remove oxidized or misfolded proteins (13) . UCH-L1 has been reported to be in association with Parkinson disease (PD), traumatic brain injury (TBI) (14) . Interestingly, it was found that gene deletion of UCH-L1 leads to progressive loss of the dopaminergic neurons in substantia nigra and striatum (15, 16) .
Another molecule related with ubiquination, transactive response DNA-binding protein (TDP-43) has been taken as neurodegerative disorders, such as Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Lobar Degeneration (FTD) (17) . TDP-43 inclusions were observed in Alzheimer' s disease (18) , Guam parkinsonism-dementia complex (19), Huntington' s disease (20) , and Hippocampal sclerosis (21) . Physiologically, TDP-43 shuttles between the nucleus, where it regulates transcription and splicing, and the cytoplasm, where it has a role on RNA transport, mRNA stability and is a component of stress granules (3, 17) . Most ALS patients show TDP-43 pathology on postmortem tissue. TDP-43 is abnormally ubiquitinated, phosphorylated, cleaved, translocated to the cytoplasm and found in aggregates in the (upper and lower) motor neurons (17, 21) .
Considering these aspects, we hypothesized that widespread TDP-43 and UCH-L1 proteinopathy may underlie multifocal neuronal dysfunction that contributes to complex non-motor phenotypes in autism, including cognitive impairment with prominent frontal executive dysfunction and extrapyramidal signs. Within this context, we aimed to investigate the serum levels of TDP-43 and UCH-L1 in children with autism.
METHODS

Participant Samples
24 children with ASD and 24 age-matched and sex-matched controls were enrolled in this study. The children in the first group were diagnosed as having autism according to Diagnostic and Statistical Manual of Mental Disorders, 4 th ed., criteria. In pediatric clinics of Medipol University Hospital, age and sex-matched children were recruited as the healthy control group. Eligible controls were evaluated by child psychiatrists. The present study was approved by the ethics committee of İstanbul University Cerrahpaşa School of Medicine. Consent forms were obtained from their parents.
Childhood Autism Rating Scale (CARS) was used to assess severity of autistic symptoms. CARS consists of 15 categories, each is rated on a fourpoint scale. An individual is considered as mild-to-moderate when scores are between 30 and 36; and severely autistic when score are between 37 and 60. The Turkish language version of CARS was used in previous studies (22) .
Procedure
Blood samples were taken after a ≥12 h fast. Blood specimens were allowed to clot for 30 minutes. They were routinely centrifuged at 4000 rpm for 10 min, and aliquots of serum samples were stored at -70 °C for measurement of TDP-43 and UCH-L1 concentration.
Measurement of TDP-43 and UCH-L1
Serum concentrations of TDP-43 and UCH-L1 were determined with an enzyme linked immunosorbent assay (ELISA) method (YEHUA Biological Technology, China, Catalog Number YHB3139Hu and YHB3139Hu, respectively), according to the manufacturer' s instructions. Briefly, samples were added to wells which are pre-coated with monoclonal antibody and let to be incubated; then, antibodies labelled with biotin were added, and combined with Streptavidin-HRP to form immune complex; then incubation and washing were carried out. Then chromogen solutions were added, and due to the effect of stop solution, the color finally became yellow. The absorbance was measured at 450 nm. Assay ranges of these kits were 20ng/L→6000ng/L for TDP-43 and 1ng/mL→38ng/mL for UCH-L1.
Statistical Analysis
Univariate data were compared using the chi-square-test for categorical variables and Mann-Whitney test. Spearman correlation analyses were applied between UCH-L1 and TDP-43. p-values of less than 0.05 were considered as significant. SPSS for Windows, v.17.0 (IBM Corporation, New York, USA) were carried out for statistical analyses Table 1 showed sociodemographic datas of the groups. 75% of the participants were boys in ASD group, and the mean age was 3.41 years (SD: 0.92), while 66.7% were boys in controls, and the mean age was 3.37 years (SD: 0.76). ASD group had no familial autism history. The mean serum TDP-43 levels were found significantly lower in children with ASD compared with controls (p<0.001; 506.21±780.97 ng/L and 1245.80± 996.76 ng/L, respectively). The mean Serum UCH-L1 levels significantly decreased in ASD group compared with controls (p<0.001; 3.08± 5.44 ng/mL and 8.64±6.67 ng/mL, respectively). Significant positive correlation was found between serum TDP-43 levels and serum levels of UCH-L1 (r=0.947, n= 24, p<0.001). The mean CARS score of ASD group was 48.91 points (SD: 5.82).
RESULTS
DISCUSSION
In recent genetic studies, it has been suggested that there is increased risk of autism for proteins related with synapse formation (23) . Ubiquitinaton-proteasomal system was thought to be important for regulating synaptic protein functions, especially in synapse. As previously shown, molecules that are involved in ubiquinination play a significant role in brain development such as synaptogenesis (5) as the balance between ubiquitination and deubiquitination is critical for synapse function (24) . For example, regulation of ubiquination via UBE3A with phoshorylation was impaired and it led to increased synapsis and dendritic spine density in an autism proband with mutant of T485 (4,5). To our knowledge, this is the first research investigating UCH-L1 and TDP-43 serum levels of ASD, in which both molecules are involved in protein formation. These preliminary study findings revealed that serum UCHL-L1 and TDP-43 levels of ASD patients were significantly lower than healthy control group. Similarly, UBE3A, which is another important molecule in ubiquitin system, is found to be associated with autistic symptoms in Angelmann syndrome (25, 26) . Therefore, impairment in ubiquitin-proteasome system might show underlying mechanism of synapse pathology in autism.
Ubiquitin C-terminal hydrolase L1 (UCHL1), and UPS molecule, are thought to be essential for synaptic function and cognition (27, 28, 29) . Altered ubiquitination resulting from abnormal UCHL1 expression may contribute to learning and memory impairment (30) . In according to these aspects, mouse models in ASD such as UBA6 brain-specific knock-out mouse suggest relation with ubiquination in autism. Lee et al. (2015) revealed that the UBA6 deficit in neuronal tissue leads to autistic symptoms (1). Beyond these, Angelmann syndrome is caused respectively by lack of or excess of UBE3A, a ubiquitin E3 ligase which leads to autistic features (31) . In addition to UBE3A, it was revealed that there was association between synaptic pathology in autism and other ubiquitin genes, including SHANKS, RFWD2, FBXO40 and PARK2 (32, 33) . Furthermore, increased UBE3A in synapse leads to suppression of glutamatergic signalling. This might show a mediator effect of ubiquitin proteasome system (e.g UBE3A, UCHL1, UBA6, genes including SHANKS, RFWD2, FBXO40 and PARK2 ) associated with neuronal activity (32). Therefore, decreased serum level of UCHL1 may reflect underlying problems in ubiquitin proteasome system. However, our findings have to be confirmed by cellular based studies.
TDP-43, RNA binding proteins, play a role in synaptic activity dynamically (34) . It was demonstrated that alteration in TDP-43 regulation in early phases of development might lead to neurodegeneration (35) . Moreover, TDP-43 protein, aggregated in FTD and ALS, was shown in ubiquitinated neuronal cytoplasmic inclusions either in central or peripheral neurons (17) . However, TDP-43 protein has been recently demonstrated to have multiple roles in the regulation of mRNA fate in neuronal cells, such as transcript stabilization and activity-dependent transport to dendrites (36, 37) . TDP-43 homeostasis might be maintained by the ubiquitin proteasome system (UPS) and autophagy (38) . Such ubiquitination, abnormal hyperphosphorylation and N-terminal cleavage 43 modifications was revealed in FTLD and ALS patients (39) . These findings were interpreted as playing a vital role in early development. Likewise, low serum level of TDP-43 in our study may show disturbed ubiquitin protesome system leading to altered development of synapse in autism.
While TDP-43 and UCH-L1 are typically regarded as intracellular proteins, they have, however, been discovered to be normally present in extracellular biological fluids, including human cerebrospinal fluid (CSF) and blood plasma (40) . It was thought that increased CSF level of TDP-43 might point critical effect of TDP-43 level in neuronal functions (41) . Furthermore, UCH-L1 which is abundant in the body of neurons in CNS, was a biomarker of neuronal injury that shows elevated CSF and serum UCH-L1 levels in ischemic stroke model (42) . However, this was not found in intracranial haemorrhage (43) . It has been also revealed that increased serum levels of UCHL-1 reflect neuropathology such as subcortical white matter lesion, as well as CSF level of UCHL-1 (44, 45) . Thus, UCHL-1 was suggested as indicator of traumatic brain injury. As shown in both elevations of UCHL-1 levels in response to neuronal injury, low serum levels might be reflection of disturbed neuroplasticity in autism. In addition, another important finding of our study was the positive correlation of these two molecules. As both molecules involved in UPS system, this association may support role of UPS system in autism. Thus, our study revealed that molecules involved in ubiquination may influence on autistic behaviours. Probably, unexplained mechanism may underlie in the pathogenesis of autism. For instance, UCH-L1 may play role in underlying mechanism in autism probably via process of ubiquitination (14) . Thus, we thought that low serum levels of UCHL1 and TDP-43 may indicate subtle dysregulation of ubiquitination in cellular aspect of autism [1] . However, this result requires further studies to be confirmed.
There are several limitations in the present study. Therefore, our study should be considered as a preliminary study. Firstly, the range of our study samples was small. Secondly, we collected only serum samples, while CSF samples were absent. Thirdly, reliability and validation of CARS have not yet been confirmed for Turkish population while study has been conducted.
CONCLUSION
Low serum levels of UCHL-L1 and TDP-43 may imply disturbed ubiquination in ASD. Posttranslation of proteins regulated by ubiquitin-proteasome system was one of the neuroplasticity mechanisms. Since protein ubiquitination is a universal reaction happening in almost every physiological process within the cell, it has still not been explained why ubiquination-related molecule abnormalities are caused in neural development. There may be some signatures in functionally important proteins which are processed during neural development. Further studies are required to identify the underlying pathogenesis of ASDs.
